An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes (Q50522405)
Jump to navigation
Jump to search
scientific article published on 20 April 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes |
scientific article published on 20 April 2011 |
Statements
An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes (English)
1 reference
Sufyan G Sayyed
1 reference
Mi Ryu
1 reference
Onkar P Kulkarni
1 reference
Holger Schmid
1 reference
Julia Lichtnekert
1 reference
Sabine GrĂ¼ner
1 reference
Luke Green
1 reference
Patrizio Mattei
1 reference
Guido Hartmann
1 reference
20 April 2011
1 reference
80
1 reference
1
1 reference
68-78
1 reference
Identifiers
1 reference